4.4 Review

The fundamental link between pneumococcal carriage and disease

期刊

EXPERT REVIEW OF VACCINES
卷 11, 期 7, 页码 841-855

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1586/ERV.12.53

关键词

herd immunity; invasive pneumococcal disease; pneumococcal carriage; pneumococcal colonization; pneumococcal vaccine licensure; pneumococcal vaccines; pneumococcus; vaccine effect on colonization

资金

  1. Bill & Melinda Gates Foundation through the Grand Challenges in Global Health Initiative
  2. Berna/Crucell
  3. Wyeth/Pfizer
  4. MSD
  5. Protea
  6. Pfizer
  7. Merck
  8. Novartis
  9. Sanofi-Pasteur
  10. GSK
  11. National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish

向作者/读者索取更多资源

Streptococcus pneumoniae (pneumococcus) is a major cause of worldwide mortality and morbidity, and to a large extent is vaccine-preventable. Nasopharyngeal carriage of pneumococcus precedes disease and is the source of pneumococcal spread between people. The use of vaccine effect on carriage as part of the vaccine licensure and post-vaccine introduction evaluation could facilitate and expand the licensure of new, life-saving pneumococcal vaccines and enable a comprehensive estimate of population effects after vaccine introduction. The authors provide a review of the evidence supporting pneumococcal carriage at the individual level as an immediate and necessary precursor to pneumococcal disease. Based on such a causal link between carriage and disease, the authors emphasize the role of information on pneumococcal carriage in vaccine trials and in public health decision-making.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据